What is Acadia Pharmaceuticals's change in AP?

Acadia Pharmaceuticals (ACAD) reported change in AP of $1.34M in Q1 2026.

How has Acadia Pharmaceuticals's change in AP changed year-over-year?

Acadia Pharmaceuticals's change in AP decreased by 29.4% year-over-year, from $1.9M to $1.34M.

What is the long-term trend for Acadia Pharmaceuticals's change in AP?

Over 3 years (2021 to 2025), Acadia Pharmaceuticals's change in AP has grown at a 48.4% compound annual growth rate (CAGR), from -$1.62M to -$5.29M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Acadia Pharmaceuticals ACAD Change in AP

Change in AP at other companies

Neurocrine BiosciencesNBIX

-$14.3M-377%

Catalyst PharmaceuticalCPRX

-$4.05M+24.9%

PTC TherapeuticsPTCT

-$68.71M-471%

BridgeBio PharmaBBIO

-$7.17M-141%

TG TherapeuticsTGTX

$34.02M-47.8%

Arrowhead ResearchARWR

$15.26M+397%

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.87B+37.0%

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's change in AP?: Acadia Pharmaceuticals (ACAD) reported change in AP of $1.34M in Q1 2026.
How has Acadia Pharmaceuticals's change in AP changed year-over-year?: Acadia Pharmaceuticals's change in AP decreased by 29.4% year-over-year, from $1.9M to $1.34M.
What is the long-term trend for Acadia Pharmaceuticals's change in AP?: Over 3 years (2021 to 2025), Acadia Pharmaceuticals's change in AP has grown at a 48.4% compound annual growth rate (CAGR), from -$1.62M to -$5.29M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.